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A B S T R A C T
Lysinibacillus and Paenibacillus are pervasive bacteria rarely associated with human disease. Less
sophisticated microbiology techniques may frequently incorrectly identify these genera as Bacillus spp.,
often regarded as environmental contamination. This report describes a case of severe sepsis due to
persistent Lysinibacillus and Paenibacillus bacteremia, identiﬁed by matrix-assisted laser desorption and
ionization time-of-ﬂight mass spectroscopy and 16S rRNA gene sequencing.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Lysinibacillus and Paenibacillus are ubiquitous Gram-positive
bacteria initially designated as Bacillus spp. and often regarded as
environmental contaminants when isolated in the clinical
microbiology laboratory, although their potential to cause human
disease has been documented.1,2 The introduction of reliable
identiﬁcation techniques such as matrix-assisted laser desorption
and ionization time-of-ﬂight mass spectroscopy and 16S rRNA
gene sequencing allows for accurate delineation of potentially
pathogenic bacteria. We report a case of severe sepsis caused by
persistent Lysinibacillus and Paenibacillus bacteremia in a patient
with a history of intravenous drug abuse and splenectomy. Our
report highlights the critical importance of accurate laboratory
techniques in the diagnosis of infectious syndromes due to
uncommonly isolated microorganisms whose pathogenicity can
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1201-9712/Published by Elsevier Ltd on behalf of International Society for Infectious
creativecommons.org/licenses/by-nc-nd/4.0/).2. Case report
A 36 year old woman with a history of splenectomy secondary
to a motor vehicle accident and intravenous heroin abuse
presented to the emergency department at The Ohio State
University Wexner Medical Center (OSUWMC) with a 10 day
history of fever, chills, emesis, myalgia, rhinorrhea and coughing.
One week prior, she was seen at an outside hospital for worsening
general malaise and was prescribed a course of oral ciproﬂoxacin
for a presumed urinary tract infection and discharged. Subse-
quently, her condition continued to deteriorate and she was unable
to eat, drink, urinate or have bowel movements and was
experiencing new left lower quadrant pain. The patient reported
that, after her discharge, the outside hospital called to inform her
that her blood cultures were positive and instructed her to begin a
new antibiotic regimen, although it is unclear whether she took
this antibiotic. On admission to OSUWMC, she was profoundly
dehydrated, hypotensive, hyperkalemic, metabolically acidotic,
and was in acute renal failure. Pertinent laboratory results on
admission included a carbon dioxide level of 16 mmol/L, blood
urea nitrogen (BUN) 132 mg/dL, serum creatnine 8.73 mg/dL,
anion gap 32, total bilirubin 1.5 mg/dL, alkaline phosphatase
162 U/L, alanine aminotransferase 121 U/L, aspartate aminotrans-
ferase 46 U/L, white blood cell count of 62,700 cells/mL with
91% segmented neutrophils, and a hemoglobin of 11.3 g/dL. A chest
x-ray revealed no acute cardiopulmonary process and a renal Diseases. This is an open access article under the CC BY-NC-ND license (http://
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the abdomen and ultrasound of the right upper quadrant revealed
signiﬁcant thickening of the gallbladder wall consistent with acute
cholecystitis although no surgical intervention was required. A
hepatobiliary iminodiacetic acid scan was recommended but the
patient refused due to lack of insurance coverage. On hospital day
three, two peripheral blood cultures collected during admission
signaled positive for Gram variable bacilli (Figure 1) using the BD
BACTEC 9240 system (Becton-Dickinson, Sparks, MD) with
charcoal-free culture bottles and the patient was started on
intravenous vancomycin and ertapenem. The Infectious Diseases
(ID) service was consulted and she was transferred to the intensive
care unit (ICU) for hypotension, but responded to a ﬂuid bolus and
never required vasopressor support. On day four of hospitalization,
her antibiotics were switched to ampicillin/sulbactam by the ID
physician due to concern for listeriosis as she remained hypoten-
sive and the Gram stain from her blood cultures was now being
reported as Gram positive bacilli. On day ﬁve, peripheral blood
cultures grew two colony types, the larger and grayer colony was
identiﬁed as Lysinibacillus fusiformis by matrix-assisted laser
desorption and ionization time-of-ﬂight mass spectroscopy
(MALDI-TOF MS) using the Bruker Microﬂex instrument, Biotyper
software version 3.0, and database version 3.1.0 (Bruker Daltonik,
Bremen, Germany) and the second smaller and whiter as
Lysinibacillus sphaericus by 16S rDNA sequencing as MALDI-TOF
MS did not generate a reliable identiﬁcation. Antibiotic susceptibili-
ties were performed via Etest (bioMe´rieux, Durham, NC) and
minimum inhibitory concentrations and interpretations are listed in
Table 1. The identiﬁcation of this polymicrobial Bacillus-like
bacterium prompted a more targeted physical exam which revealed
that the patient had very poor dentition. A Panorex exposed a focal
lucency around tooth 15 that was consistent with abscess
formation. On day six, the patient was transferred out of the ICU
as her hypotension and acute renal failure had resolved. Her
peripheral blood cultures were again positive for Lysinibacillus spp.Figure 1. Gram variable rod (1000x).
Table 1
L. fusiformis and L. sphaericus antibiotic susceptibilities
Antibiotic L. fusiformis L. sphaericus
MIC Interpretation MIC Interpretation
Ceftriaxone 4 S - -
Linezolid 0.75 U 1 U
Moxiﬂoxacin 0.38 U 0.125 U
Penicillin 0.12 S 0.125 S
Vancomycin 2 S 1 Salong with Paenibacillus amylolyticus identiﬁed using MALDI-TOF
MS and 16s rRNA sequencing. The patient then decided to leave
against medical advice with no antibiotic therapy.
The next day, the ID team was notiﬁed by the clinical
microbiology laboratory that fungal elements were seen on Gram
stain for both sets of blood culture taken on hospital day three.
Consequently, the ID team contacted the patient and persuaded her
to return to the hospital for additional antimicrobial therapy. Upon
readmission, she had no subjective complaints and was treated with
ampicillin/sulbactam and caspofungin. Repeat blood cultures were
drawn and were again positive for Paenibacillus amylolyticus and
Bacillus spp. The ID team recommended drainage of the dental
abscess along with a dilated fundus exam and transesophageal
echocardiogram due to presumed candidemia, which were both
negative for endopthalmitis and endocarditis, respectively. Fungal
elements seen on Gram stain were non-viable on culture and
determined only to resemble zygomycetes. Before further diagnostic
or therapeutic modalities could be employed, the patient again
decided to leave against medical advice. She was given a prescription
for amoxicillin/clavulanate with no further follow up available. Her
last set of blood cultures from day three of the second hospital
admission ﬁnalized as no growth after ﬁve days of incubation.
3. Discussion
Lysinibacillus spp., are Gram positive or Gram variable, aerobic or
facultative anaerobic rod-shaped bacilli that form endospores,
tolerate extremes of environment and are ubiquitous.1 Initially
designated B. sphaericus, the name was subsequently changed based
on the distinctive peptidoglycan composition of its cell wall, along
with further phylogenetic and physiological analyses.3 Organisms
within the Bacillus genus often show only subtle distinctions from
one another on chromosomal DNA sequencing, likely due to a high
prevalence of lateral gene transfer. Despite this commonality, there
are often pronounced clinical differences between disease states
caused by speciﬁc species.1 L. sphaericus is fairly large in size and
grows easily on culture media at environmental temperatures, but is
rarely isolated from human specimens.1
Bacillus spp. and related bacteria such as Lysinibacillus spp. are
commonly regarded as contaminants if isolated in the laboratory
primarily due to their ubiquitous nature and perceived lack of
pathogenicity. Despite this perception, they have been known to
cause serious infections in humans. Bacteremia has been the most
common presentation of systemic infections due to Bacillus
species, particularly associated with the presence of an intravas-
cular or surgically implanted catheter. Disseminated Bacillus spp.
infections have been reported in neonates, neutropenic patients
and injection drug users. The largest case report of L. sphaericus
bacteremia to our knowledge represented 12 cases over a 10 year
period at a children’s cancer hospital in Italy.2 L. sphaericus was
demonstrated to cause 12 out of 469 (2%) episodes of bacteremia in
children with cancer or those undergoing bone marrow transplant.
All isolates were susceptible to ﬂuoroquinolones and all 12 patients
were treated with ciproﬂoxacin and survived.
Although speciﬁc antibiotic therapy is not indicated for all
infections due to Bacillus species, removal of prosthetic material
and implanted catheters seems to be vital to achieve cure.3 The
majority of Bacillus species are susceptible to vancomycin,
clindamycin, ﬂuoroquinolones, aminoglycosides and carbapenems
while penicillin and cephalosporin susceptibility is variable.
Overall, the reported susceptibilities in our case were similar to
previous literature primarily focused on the Bacillus species4,5
although both of this patient’s Lysinibacillus isolates demonstrated
susceptibility to penicillin.
Paenibacillus is a spore-forming Gram positive, mesophilic,
heterotrophic rod, which was ﬁrst isolated and identiﬁed as a
E. Wenzler et al. / International Journal of Infectious Diseases 35 (2015) 93–95 95novel species by the Jet Propulsion Laboratory Spacecraft
Assembly Facility in December 2000.6 Paenibacillus spp. are also
ubiquitous and found in the environment. Some members of the
Paenibacilli were originally classiﬁed as bacilli but then reclassi-
ﬁed as Paenibacillus genus. Because of the genetic similarity to
Bacillus spp., treatment is chosen according to the standard
treatment of Bacillus spp. (i.e. B cereus) in the absence of
sensitivity testing. There are more than 100 species identiﬁed
in the genus Paenibacillus although exceedingly few have been
found to cause human disease, with P. alvei being the most
common. In the literature, multiple infectious syndromes
associated with P. alvei have been described, including pneumonia
and endophalmitis.7–10
This report represents a rare case of bacteremia due to
Lysinibacillus and Paenibacillus spp. in an immunocompetent
patient without implanted prosthesis or intravascular catheters.
To our knowledge, bacteremia due to Bacillus-like species has not
been associated with poor dentition or odontological disease.
Although the undrained dental abscess could have been a potential
source of her persistent bacteremia, her history of intravenous
drug abuse and splenectomy likely also contributed, despite her
claims of abstinence from heroin. Clinically relevant infections
with Lysinibacillus and Paenibacillus species are uncommon but
proper management with aggressive source control and timely,
susceptibility-guided antibiotic therapy are essential for optimal
clinical outcomes.Transparency declarations: All authors have no conﬂicts of
interest to disclose
Funding: There was no ﬁnancial support for this work.
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